211 related articles for article (PubMed ID: 27878832)
1. Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs.
Giles ME; Murphy L; Krstić N; Sullivan C; Hashmi SS; Stevens B
Prenat Diagn; 2017 Feb; 37(2):126-132. PubMed ID: 27878832
[TBL] [Abstract][Full Text] [Related]
2. NIPT: current utilization and implications for the future of prenatal genetic counseling.
Buchanan A; Sachs A; Toler T; Tsipis J
Prenat Diagn; 2014 Sep; 34(9):850-7. PubMed ID: 24711206
[TBL] [Abstract][Full Text] [Related]
3. The use of noninvasive prenatal testing in obstetric care: educational resources, practice patterns, and barriers reported by a national sample of clinicians.
Farrell RM; Agatisa PK; Mercer MB; Mitchum AG; Coleridge MB
Prenat Diagn; 2016 Jun; 36(6):499-506. PubMed ID: 26991091
[TBL] [Abstract][Full Text] [Related]
4. Talking about disability in prenatal genetic counseling: a report of two interactive workshops.
Hodgson J; Weil J
J Genet Couns; 2012 Feb; 21(1):17-23. PubMed ID: 22037895
[TBL] [Abstract][Full Text] [Related]
5. An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing.
Bernhardt BA; Kellom K; Barbarese A; Faucett WA; Wapner RJ
J Genet Couns; 2014 Dec; 23(6):938-47. PubMed ID: 24569858
[TBL] [Abstract][Full Text] [Related]
6. The impact of insurance coverage on the prenatal genetic counseling process: An exploration of genetic counselors' experiences with TRICARE.
Brown J; O'Neill S; DiNonno W; Hess O
Prenat Diagn; 2019 May; 39(6):448-455. PubMed ID: 30883831
[TBL] [Abstract][Full Text] [Related]
7. The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.
Suskin E; Hercher L; Aaron KE; Bajaj K
J Genet Couns; 2016 Oct; 25(5):1032-43. PubMed ID: 26879922
[TBL] [Abstract][Full Text] [Related]
8. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
[TBL] [Abstract][Full Text] [Related]
9. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.
Agatisa PK; Mercer MB; Coleridge M; Farrell RM
J Genet Couns; 2018 Dec; 27(6):1374-1385. PubMed ID: 29951719
[TBL] [Abstract][Full Text] [Related]
10. [Utterly unanticipated findings].
Jordan B
Med Sci (Paris); 2015 May; 31(5):567-8. PubMed ID: 26059309
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors.
Devers PL; Cronister A; Ormond KE; Facio F; Brasington CK; Flodman P
J Genet Couns; 2013 Jun; 22(3):291-5. PubMed ID: 23334531
[TBL] [Abstract][Full Text] [Related]
12. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.
Langfelder-Schwind E; Karczeski B; Strecker MN; Redman J; Sugarman EA; Zaleski C; Brown T; Keiles S; Powers A; Ghate S; Darrah R
J Genet Couns; 2014 Feb; 23(1):5-15. PubMed ID: 24014130
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland.
Aebi-Popp K; Kahlert C; Rauch A; Mosimann B; Baud D; Low N; Surbek D
Swiss Med Wkly; 2016; 146():w14325. PubMed ID: 27399957
[TBL] [Abstract][Full Text] [Related]
15. Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.
Gammon BL; Otto L; Wick M; Borowski K; Allyse M
J Genet Couns; 2018 Aug; 27(4):894-901. PubMed ID: 29247311
[TBL] [Abstract][Full Text] [Related]
16. Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing.
Walser SA; Kellom KS; Palmer SC; Bernhardt BA
Prenat Diagn; 2015 Sep; 35(9):870-8. PubMed ID: 25995037
[TBL] [Abstract][Full Text] [Related]
17. Emerging issues in invasive prenatal diagnosis: Safety and competency in the post-NIPT era.
Hui L; The S; McCarthy EA; Walker SP
Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):541-6. PubMed ID: 26303213
[TBL] [Abstract][Full Text] [Related]
18. A survey of genetic counselors' use of informed consent documents for prenatal genetic counseling sessions.
Jacobson GM; Veach PM; LeRoy BS
J Genet Couns; 2001 Feb; 10(1):3-24. PubMed ID: 11767800
[TBL] [Abstract][Full Text] [Related]
19. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
20. Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
Stoll K; Norton ME
Semin Perinatol; 2018 Aug; 42(5):296-302. PubMed ID: 30209012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
